HRHermann Rohrer

Hermann Rohrer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hermann Rohrer has a total of 50 co-authors. Here are the top co-authors by number of shared publications:

  • Jutta Stubbusch

    Developmental Neurobiology, Max-Planck-Institute for Brain Research, Max-von-Laue-Str. 4, Frankfurt/M, 60438, Germany

    3 shared publications
  • Marco Kramer

    Max-Planck-Institute for Brain Research, Developmental Neurobiology, 60438 Frankfurt/Main, Germany

    3 shared publications
  • Melanie Hennchen

    Developmental Neurobiology, Max Planck Institute for Brain Research, 60438 Frankfurt am Main, Germany

    3 shared publications
  • Thomas Deller

    Institute of Clinical Neuroanatomy, Goethe University Frankfurt/Main, 60590 Frankfurt/Main, Germany

    3 shared publications
  • Uwe Ernsberger

    Developmental Neurobiology, Max-Planck-Institute for Brain Research, Max-von-Laue-Str. 4, Frankfurt/M, 60438, Germany

    3 shared publications
  • Isabelle Janoueix-Lerosey

    INSERM U830, Laboratoire de Génétique et Biologie des Cancers, Institut Curie, Paris, France

    2 shared publications

Latest Publications

  • Open Access

    Proliferation and Survival of Embryonic Sympathetic Neuroblasts by MYCN and Activated ALK Signaling

    by Marco Kramer, Diogo Ribeiro, Marie Arsenian-Henriksson, Thomas Deller, Hermann Rohrer

    Neuroblastoma (NB) is a childhood tumor that arises from the sympathoadrenal lineage.MYCNamplification is the most reliable marker for poor prognosis andMYCNoverexpression in embryonic mouse sympathetic ganglia results in NB-like tumors. MYCN cooperates with mutational activation of anaplastic lymphoma kinase (ALK), which promotes progression to NB, but the role of MYCN and ALK in tumorigenesis is still poorly understood. Here, we use chick sympathetic neuroblasts to examine the normal function ofMYCNandMYCin the control of neuroblast proliferation, as well as effects of overexpression ofMYCN,MYC, and activated ALK, alone and in combination. We demonstrate thatMYCis more strongly expressed thanMYCNduring neurogenesis and is important forin vitroneuroblast proliferation.MYCandMYCNoverexpression elicits increased proliferation but does not sustain neuroblast survival. Unexpectedly, long-term expression of activatedALKF1174Lleads to cell-cycle arrest and promotes differentiation and survival of postmitotic neurons.ALKF1174LinducesNEFM,RET, andVACHTand results in decreased expression of proapototic (BMF, BIM), adrenergic (TH), and cell-cycle genes (e.g.,CDC25A, CDK1). In contrast, neuroblast proliferation is maintained whenMYCNandALKF1174Lare coexpressed. ProliferatingMYCN/ALKF1174Lneuroblasts display a differentiated phenotype but differ fromALK-expressing neurons by the upregulation ofSKP2,CCNA2,E2F8, andDKC1. Inhibition of the ubiquitin ligase SKP2 (S-phase kinase-associated protein 2), which targets the CDK inhibitor p27 for degradation, reduces neuroblast proliferation, implicating SKP2 in the maintained proliferation ofMYCN/ALKF1174Lneuroblasts. Together, our results characterize MYCN/ALK cooperation leading to neuroblast proliferation and survival that may represent initial steps toward NB development.SIGNIFICANCE STATEMENTMYCN overexpression combined with activated anaplastic lymphoma kinase (ALK) is sufficient to induce neuroblastoma (NB) in mouse sympathoadrenal cells. To address cellular and molecular effects elicited by MYCN/ALK cooperation, we used cultures of chick sympathetic neuroblasts. We demonstrate thatMYCNincreases proliferation but not survival, whereas long-term expression ofALKF1174Lelicits cell-cycle exit, differentiation, and survival of postmitotic neurons. CombinedMYCN/ALKF1174Lexpression allows long-term proliferation and survival of neuroblasts with differentiated characteristics. In the presence ofALKF1174Lsignaling,MYCNinduces the expression of the ubiquitin ligase SKP2 (S-phase kinase-associated protein 2), which targets p27 for degradation and is also upregulated in high-risk NB. SKP2 inhibition supports a function for SKP2 in the maintained neuroblast proliferation downstream of MYCN/ALK, which may represent an early step toward tumorigenesis.


  • Distinct roles of hand2 in developing and adult autonomic neurons

    by Sabine Stanzel, Jutta Stubbusch, Abhijeet Pataskar, Marthe J. Howard, Thomas Deller, Uwe Ernsberger, Vijay K. Tiwari, Hermann Rohrer, Konstantina Tsarovina

    The bHLH transcription factor Hand2 is essential for the acquisition and maintenance of noradrenergic properties of embryonic sympathetic neurons and controls neuroblast proliferation. Hand2 is also expressed in embryonic and postnatal parasympathetic ganglia and remains expressed in sympathetic neurons up to the adult stage. Here, we address its function in developing parasympathetic and adult sympathetic neurons. We conditionally deleted Hand2 in the parasympathetic sphenopalatine ganglion by crossing a line of floxed Hand2 mice with DbhiCre transgenic mice, taking advantage of the transient Dbh expression in parasympathetic ganglia. Hand2 elimination does not affect Dbh expression and sphenopalatine ganglion size at E12.5 and E16.5, in contrast to sympathetic ganglia. These findings demonstrate different functions for Hand2 in the parasympathetic and sympathetic lineage. Our previous Hand2 knockdown in postmitotic, differentiated chick sympathetic neurons resulted in decreased expression of noradrenergic marker genes but it was unclear whether Hand2 is required for maintaining noradrenergic neuron identity in adult animals. We now show that Hand2 elimination in adult Dbh‐expressing sympathetic neurons does not decrease the expression of Th and Dbh, in contrast to the situation during development. However, gene expression profiling of adult sympathetic neurons identified 75 Hand2‐dependent target genes. Interestingly, a notable proportion of down‐regulated genes (15%) encode for proteins with synaptic and neurotransmission functions. These results demonstrate a change in Hand2 target genes during maturation of sympathetic neurons. Whereas Hand2 controls genes regulating noradrenergic differentiation during development, Hand2 seems to be involved in the regulation of genes controlling neurotransmission in adult sympathetic neurons. © 2016 Wiley Periodicals, Inc. Develop Neurobiol 76: 1111–1124, 2016


  • Open Access

    Lin28B and Let-7 in the Control of Sympathetic Neurogenesis and Neuroblastoma Development

    by Melanie Hennchen, Jutta Stubbusch, Ikram Abarchan-El Makhfi, Marco Kramer, Thomas Deller, Cécile Pierre-Eugene, Isabelle Janoueix-Lerosey, Olivier Delattre, Uwe Ernsberger, Johannes B. Schulte, et al.

    The RNA binding protein Lin28B is expressed in developing tissues and sustains stem and progenitor cell identity as a negative regulator of theLet-7family of microRNAs, which induces differentiation. Lin28B is activated in neuroblastoma (NB), a childhood tumor in sympathetic ganglia and adrenal medulla. Forced expression of Lin28B in embryonic mouse sympathoadrenal neuroblasts elicits postnatal NB formation. However, the normal function of Lin28B in the development of sympathetic neurons and chromaffin cells and the mechanisms involved in Lin28B-induced tumor formation are unclear. Here, we demonstrate a mirror-image expression ofLin28BandLet-7ain developing chick sympathetic ganglia.Lin28Bexpression is not restricted to undifferentiated progenitor cells but, is observed in proliferating noradrenergic neuroblasts.Lin28knockdown in cultured sympathetic neuroblasts decreases proliferation, whereasLet-7inhibition increases the proportion of neuroblasts in the cell cycle. Lin28B overexpression enhances proliferation, but only during a short developmental period, and it does not reduceLet-7a. Effects ofin vivo Lin28Boverexpression were analyzed in theLSL-Lin28BDBHiCremouse line. Sympathetic ganglion and adrenal medulla volume and the expression level ofLet-7awere not altered, althoughLin28Bexpression increased by 12- to 17-fold. In contrast,Let-7aexpression was strongly reduced inLSL-Lin28BDbhiCreNB tumor tissue. These data demonstrate essential functions for endogenousLin28andLet-7in neuroblast proliferation. However,Lin28Boverexpression neither sustains neuroblast proliferation nor affects let-7 expression. Thus, in contrast to other pediatric tumors,Lin28B-induced NB is not due to expansion of proliferating embryonic neuroblasts, and Let-7-independent functions are implicated during initial NB development.SIGNIFICANCE STATEMENTLin28A/B proteins are highly expressed in early development and maintain progenitor cells by blocking the biogenesis and differentiation function of Let-7 microRNAs. Lin28B is aberrantly upregulated in the childhood tumor neuroblastoma (NB). NB develops in sympathetic ganglia and adrenal medulla and is elicited by forced Lin28B expression. We demonstrate that Lin28A/B and Let-7 are essential for sympathetic neuroblast proliferation during normal development. Unexpectedly, Lin28B upregulation in a mouse model does not affect neuroblast proliferation, ganglion size, and Let-7 expression during early postnatal development. Lin28B-induced NB, in contrast to other pediatric cancers, does not evolve from neuroblasts that continue to divide and involves Let-7-independent functions during initial development.


  • Prox1 identifies proliferating neuroblasts and nascent neurons during neurogenesis in sympathetic ganglia

    by Julia Holzmann, Melanie Hennchen, Hermann Rohrer

    Neurogenesis in embryonic sympathetic ganglia involves neuroblasts that resume proliferation following neuronal differentiation. As cell cycle exit is not associated with neuronal differentiation, the identity of proliferating neuroblasts is incompletely understood. Here, we use sympathetic ganglia of chick embryos to define the timing of neurogenesis and neuroblast identity focusing on the expression and function of the transcription factor Prox1. We show that a large fraction of neuroblasts has initially withdrawn from the cell cycle at embryonic day 3 (E3), which is reflected by a high proportion of p27(+) /Islet1(+) neuroblasts (63%) and low numbers of EdU(+) /Islet1(+) cells (12%). The proportion of proliferating Islet1(+) neuroblasts, identified by EdU pulse labeling and by the absence of the postmitotic marker p27 increases to reach maximal levels at E5, when virtually all neuroblasts are in the cell cycle (95%). Subsequently, the proportion of EdU-labeled and p27(-) neuroblasts is reduced to reach low levels at E11. Interestingly, the expression of the transcription factor Prox1 is restricted to the neuronal lineage, that is, Sox10(+) /Phox2b(+) neuron progenitors, proliferating p27(-) /Islet1(+) neuroblasts and nascent neurons but is rapidly lost in postmitotic neurons. In vitro and in vivo knockdown and overexpression experiments demonstrate effects of Prox1 in the support of neuroblast proliferation and survival. Taken together, these results define the neurogenesis period in the chick paravertebral sympathetic ganglia including an initial cell cycle withdrawal and identify Prox1 as a marker and regulator of proliferating sympathetic neuroblasts. © 2015 Wiley Periodicals, Inc. Develop Neurobiol, 2015.


  • Lineage and stage specific requirement for Dicer1 in sympathetic ganglia and adrenal medulla formation and maintenance

    by Jutta Stubbusch, Priyanka Narasimhan, Melanie Hennchen, Katrin Huber, Klaus Unsicker, Uwe Ernsberger, Hermann Rohrer


  • Open Access

    Proceedings of the fourth international conference on central hypoventilation

    by the European Central Hypoventilation Syndrome Consortium, Ha Trang, Jean-François Brunet, Hermann Rohrer, Jorge Gallego, Jeanne Amiel, Tiziana Bachetti, Kenneth H Fischbeck, Thomas Similowski, Christian Straus, et al.

    Central hypoventilation syndromes (CHS) are rare diseases of central autonomic respiratory control associated with autonomous nervous dysfunction. Severe central hypoventilation is the hallmark and the most life-threatening feature. CHS is a group of not-fully defined disorders. Congenital CHS (CCHS) (ORPHA661) is clinically and genetically well-characterized, with the disease-causing gene identified in 2003. CCHS presents at birth in most cases, and associated with Hirschsprung’s disease (ORPHA99803) and neural crest tumours in 20% and 5% of cases, respectively. The incidence of CCHS is estimated to be 1 of 200,000 live births in France, yet remains unknown for the rest of the world. In contrast, late-onset CHS includes a group of not yet fully delineated diseases. Overlap with CCHS is likely, as a subset of patients harbours PHOX2B mutations. Another subset of patients present with associated hypothalamic dysfunction. The number of these patients is unknown (less than 60 cases reported worldwide). Treatment of CHS is palliative using advanced techniques of ventilation support during lifetime. Research is ongoing to better understand physiopathological mechanisms and identify potential treatment pathways. The Fourth International Conference on Central Hypoventilation was organised in Warsaw, Poland, April 13–15, 2012, under the patronage of the European Agency for Health and Consumers and Public Health European Agency of European Community. The conference provided a state-of-the-art update of knowledge on all the genetic, molecular, cellular, and clinical aspects of these rare diseases.


  • Open Access

    Alternative Generation of CNS Neural Stem Cells and PNS Derivatives from Neural Crest-Derived Peripheral Stem Cells

    by Marlen Weber, Galina Apostolova, Darius Widera, Michel Mittelbronn, Georg Dechant, Barbara Kaltschmidt, Hermann Rohrer

    Neural crest-derived stem cells (NCSCs) from the embryonic peripheral nervous system (PNS) can be reprogrammed in neurosphere (NS) culture to rNCSCs that produce central nervous system (CNS) progeny, including myelinating oligodendrocytes. Using global gene expression analysis we now demonstrate that rNCSCs completely lose their previous PNS characteristics and acquire the identity of neural stem cells derived from embryonic spinal cord. Reprogramming proceeds rapidly and results in a homogenous population of Olig2-, Sox3-, and Lex-positive CNS stem cells. Low-level expression of pluripotency inducing genes Oct4, Nanog, and Klf4 argues against a transient pluripotent state during reprogramming. The acquisition of CNS properties is prevented in the presence of BMP4 (BMP NCSCs) as shown by marker gene expression and the potential to produce PNS neurons and glia. In addition, genes characteristic for mesenchymal and perivascular progenitors are expressed, which suggests that BMP NCSCs are directed toward a pericyte progenitor/mesenchymal stem cell (MSC) fate. Adult NCSCs from mouse palate, an easily accessible source of adult NCSCs, display strikingly similar properties. They do not generate cells with CNS characteristics but lose the neural crest markers Sox10 and p75 and produce MSC-like cells. These findings show that embryonic NCSCs acquire a full CNS identity in NS culture. In contrast, MSC-like cells are generated from BMP NCSCs and pNCSCs, which reveals that postmigratory NCSCs are a source for MSC-like cells up to the adult stage. Stem Cells 2015;33:574–588


  • Following the same nerve track toward different cell fates

    by Chaya Kalcheim, Hermann Rohrer

    Schwann cell precursors can become either neurons or glia. [Also see Reports by Espinosa-Medina et al. and Dyachuk et al. ]


  • Open Access

    Synaptic protein and pan-neuronal gene expression and their regulation by Dicer-dependent mechanisms differ between neurons and neuroendocrine cells

    by Jutta Stubbusch, Priyanka Narasimhan, Katrin Huber, Klaus Unsicker, Hermann Rohrer, Uwe Ernsberger

    Background: Neurons in sympathetic ganglia and neuroendocrine cells in the adrenal medulla share not only their embryonic origin from sympathoadrenal precursors in the neural crest but also a range of functional features. These include the capacity for noradrenaline biosynthesis, vesicular storage and regulated release. Yet the regulation of neuronal properties in early neuroendocrine differentiation is a matter of debate and the developmental expression of the vesicle fusion machinery, which includes components found in both neurons and neuroendocrine cells, is not resolved. Results: Analysis of synaptic protein and pan-neuronal marker mRNA expression during mouse development uncovers profound differences between sympathetic neurons and adrenal chromaffin cells, which result in qualitatively similar but quantitatively divergent transcript profiles. In sympathetic neurons embryonic upregulation of synaptic protein mRNA follows early and persistent induction of pan-neuronal marker transcripts. In adrenal chromaffin cells pan-neuronal marker expression occurs only transiently and synaptic protein messages remain at distinctly low levels throughout embryogenesis. Embryonic induction of synaptotagmin I (Syt1) in sympathetic ganglia and postnatal upregulation of synaptotagmin VII (Syt7) in adrenal medulla results in a cell type-specific difference in isoform prevalence. Dicer 1 inactivation in catecholaminergic cells reduces high neuronal synaptic protein mRNA levels but not their neuroendocrine low level expression. Pan-neuronal marker mRNAs are induced in chromaffin cells to yield a more neuron-like transcript pattern, while ultrastructure is not altered. Conclusions: Our study demonstrates that remarkably different gene regulatory programs govern the expression of synaptic proteins in the neuronal and neuroendocrine branch of the sympathoadrenal system. They result in overlapping but quantitatively divergent transcript profiles. Dicer 1-dependent regulation is required to establish high neuronal mRNA levels for synaptic proteins and to maintain repression of neurofilament messages in neuroendocrine cells.


  • Transcriptional control of differentiation and neurogenesis in autonomic ganglia

    by Hermann Rohrer

    Autonomic neuron development is controlled by a network of transcription factors, which is induced by bone morphogenetic protein signalling in neural crest progenitor cells. This network intersects with a transcriptional program in migratory neural crest cells that pre‐specifies autonomic neuron precursor cells. Recent findings demonstrate that the transcription factors acting in the initial specification and differentiation of sympathetic neurons are also important for the proliferation of progenitors and immature neurons during neurogenesis. Elimination of Phox2b, Hand2 and Gata3 in differentiated neurons affects the expression of subtype‐specific and/or generic neuronal properties or neuron survival. Taken together, transcription factors previously shown to act in initial neuron specification and differentiation display a much broader spectrum of functions, including control of neurogenesis and the maintenance of subtype characteristics and survival of mature neurons.